Covance
Covance's Overview
Covance Drug Development, now fully integrated into Labcorp Drug Development following its acquisition by Labcorp in 2015, was a globally recognized contract research organization (CRO). It provided a comprehensive suite of services to pharmaceutical and biotechnology companies to support the entire drug development continuum. These services ranged from early-stage discovery and preclinical research to clinical trial management (Phase I-IV), central laboratory services, bioanalytical testing, and market access solutions. Covance was known for its scientific expertise and commitment to helping clients accelerate the development of new medicines.
Where is Covance's Headquarters?
HQ Function
Historically served as the global corporate headquarters for Covance, overseeing strategic direction, operations, and administrative functions before the Labcorp acquisition.
Notable Features:
The Princeton campus was a major operational hub with significant office and laboratory facilities tailored for drug development services.
Work Culture:
Covance historically fostered a science-driven and client-centric work culture, emphasizing quality, innovation, and collaboration in advancing pharmaceutical research.
HQ Significance:
The Princeton headquarters symbolized Covance's status as a leading CRO and its strong presence within the New Jersey/Pennsylvania pharmaceutical corridor.
Values Reflected in HQ: The historical HQ reflected Covance's commitment to scientific rigor, comprehensive service offerings, and supporting global health advancements.
Location:
Following its integration into Labcorp, the capabilities of the former Covance Drug Development are now part of Labcorp Drug Development's extensive global network. Labcorp Drug Development operates in over 60 countries, providing comprehensive support for global drug development. This includes early discovery services, preclinical research, full-spectrum clinical trial management (Phase I-IV), expansive central laboratory services, biomarker discovery and development, advanced bioanalytical services, and strategic market access and commercialization support. This global infrastructure allows for the execution of complex international studies and a wide array of services tailored to diverse regulatory environments and client needs worldwide.
Street Address:
210 Carnegie Center Drive (Historical Covance Global HQ)
City:
Princeton
State/Province:
New Jersey
Country:
USA
Covance's Global Presence
Madison, Wisconsin, USA
Address: 3301 Kinsman Blvd, Madison, WI 53704, USA (Major Labcorp Drug Development site, historically a key Covance facility)
Serves as a crucial North American hub for comprehensive preclinical research and analytical laboratory services for global pharmaceutical and biotech clients.
Geneva, Switzerland / Epalinges, Switzerland
Address: Route de la Corniche 9A, 1066 Epalinges, Switzerland (Key Labcorp Central Laboratory)
Essential for supporting multinational clinical trials requiring standardized, high-quality laboratory testing and efficient logistics within the EMEA region.
Indianapolis, Indiana, USA
Address: 8211 SciCor Drive, Indianapolis, IN 46214, USA (Significant clinical research and central lab site)
Key U.S. site supporting global clinical trials with comprehensive lab testing and logistical capabilities.
Harrogate, United Kingdom
Address: Otley Road, Harrogate, North Yorkshire, HG3 1PY, UK (Important European research facility)
Supports drug development programs for European and global clients with specialized scientific expertise and facilities.
Buying Intent Signals for Covance
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Covance
As of April 2025, Covance' leadership includes:
Investors of Covance
Covance has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Covance Drug Development was acquired by Labcorp in 2015 and is now fully integrated as Labcorp Drug Development. Therefore, there are no executive new hires or exits specifically for 'Covance Drug Development' as a standalone entity in the last 12 months. Any leadership changes would pertain to Labcorp or its Labcorp Drug Development segment.
Departures
New Appointments:
Technology (Tech Stack) used by Covance
Discover the tools Covance uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Covance Email Formats and Examples
Since Covance is now part of Labcorp, email communications would use Labcorp's standard email formats. The most common format for Labcorp employees is typically [first].[last]@labcorp.com. Other formats like [first_initial][last]@labcorp.com might exist but are less common for general communication.
[first].[last]@labcorp.com
Format
jane.doe@labcorp.com
Example
90%
Success rate
News and media
Business Wire • May 7, 2024
Labcorp Launches Labcorp Clinical Trial Recruitment Solution to Accelerate Patient Enrollment
Labcorp announced the launch of its Labcorp Clinical Trial Recruitment solution, an end-to-end offering designed to accelerate patient enrollment in clinical trials, leveraging Labcorp's extensive data and patient network....more
Business Wire • April 25, 2024
Labcorp Reports 2024 First Quarter Results
Labcorp announced its financial results for the first quarter of 2024, providing updates on its Diagnostics Laboratories and Drug Development segments, highlighting sustained demand in Drug Development....more
Fierce Biotech • March 4, 2024
Labcorp streamlines early drug development with launch of new 'Logix' service suite
Labcorp Drug Development launched Labcorp Logix, an integrated suite of services aimed at simplifying and accelerating early-phase drug development for biotech and pharmaceutical companies, enhancing efficiency from discovery through preclinical stages....more
Labcorp Newsroom • February 15, 2024
Labcorp Reports 2023 Fourth Quarter and Full Year Results; Introduces 2024 Guidance
Labcorp released its Q4 and full-year 2023 financial results, discussing the performance of its Drug Development segment (formerly Covance) and outlining strategic priorities for growth in 2024....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Covance, are just a search away.